The authors of the original article “Rivastigmine attenuates the Alzheimer's disease related protein degradation and apoptotic neuronal death signalling” (Biochem J (2021) 478 (7): 1435–1451; https://doi.org/10.1042/BCJ20200754.) would like to correct an error in Figure 4. The authors have identified an error in Figure 4 related to two statistical asterisks (*). As reported in the result section, the chymotrypsin activity of cortex and HP (hippocampus) regions was not significantly altered in STZ administered rats (Con vs. STZ), while by mistake the statistical marks were pasted on bars. The corrected Figure 4 is included in this Correction. The authors apologise for this oversight and any inconvenience it may have caused.The corrected figure and its legend/equation is presented below. The authors declare that this Correction does not change the results or conclusions of the original paper.

中文翻译：

---

更正：卡巴拉汀减弱与阿尔茨海默病相关的蛋白质降解和凋亡神经元死亡信号

原始文章“卡巴拉汀减弱与阿尔茨海默病相关的蛋白质降解和凋亡神经元死亡信号”（Biochem J (2021) 478 (7): 1435–1451; https://doi.org/10.1042/BCJ20200754.）的作者将喜欢纠正图 4 中的错误。作者在图 4 中发现了与两个统计星号 (*) 相关的错误。如结果部分所述，STZ 给药大鼠（Con vs. STZ）的皮质和 HP（海马）区域的糜蛋白酶活性没有显着改变，而统计标记被错误地粘贴在条形图上。更正后的图 4 包含在此更正中。作者对这一疏忽及其可能造成的任何不便深表歉意。更正的数字及其图例/方程式如下所示。